pubmed-article:18250412 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0025926 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1513867 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1332717 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1706438 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0567416 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0085358 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1416467 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1413244 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C2698600 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1418401 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:18250412 | lifeskim:mentions | umls-concept:C1998811 | lld:lifeskim |
pubmed-article:18250412 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:18250412 | pubmed:dateCreated | 2008-2-5 | lld:pubmed |
pubmed-article:18250412 | pubmed:abstractText | Systemic lupus erythematosus is an autoimmune disease caused primarily by autoantibodies (including IgG anti-DNA) and immune complexes that cause tissue damage. After tolerization with an artificial peptide (pConsensus, pCons) based on murine anti-DNA IgG sequences containing MHC class I and class II T cell determinants, lupus-prone (NZB x NZW)F(1) female (BWF(1)) mice develop regulatory CD4+CD25+ T cells and inhibitory CD8+ T cells, both of which suppress anti-DNA Ig production and immune glomerulonephritis. In the present work, we show that splenocytes from BWF(1) mice treated with pCons had significant expansion of primarily CD8+ T cells. CD4+ T cells and B cells were each directly suppressed by CD8+ T cells from tolerized mice in a contact-independent manner. Both pCons-induced CD8+CD28+ and CD8+CD28- T cells suppressed production of anti-DNA in vitro. Silencing with small interfering RNA of Foxp3 abrogated the suppression mediated by both CD8+ T cell subsets. Additionally, CD8+ T cells from tolerized mice were weakly cytotoxic against syngeneic B cells from old anti-DNA-producing mice, but not from young mice. Importantly, pCons treatment had dual effects on CD8+ suppressor T cells from tolerized mice, increasing the intracellular expression of Foxp3 while decreasing the surface expression of PD1 molecules. Blocking PD1/PDL1 interactions in the CD8+ T cells from tolerized mice reduced their expression of Foxp3 and their ability to suppress CD4+CD25- proliferation. In contrast, blocking PD1/PDL1 in naive T cells increased Foxp3 expression. Our data suggest that tolerization with pCons activates different subsets of inhibitory/cytotoxic CD8+ T cells whose targets are both CD4+CD25- effector T cells and B cells. | lld:pubmed |
pubmed-article:18250412 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:language | eng | lld:pubmed |
pubmed-article:18250412 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18250412 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18250412 | pubmed:month | Feb | lld:pubmed |
pubmed-article:18250412 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:18250412 | pubmed:author | pubmed-author:HahnBevra HBH | lld:pubmed |
pubmed-article:18250412 | pubmed:author | pubmed-author:La... | lld:pubmed |
pubmed-article:18250412 | pubmed:author | pubmed-author:SinghRam... | lld:pubmed |
pubmed-article:18250412 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18250412 | pubmed:day | 15 | lld:pubmed |
pubmed-article:18250412 | pubmed:volume | 180 | lld:pubmed |
pubmed-article:18250412 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18250412 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18250412 | pubmed:pagination | 2069-80 | lld:pubmed |
pubmed-article:18250412 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:meshHeading | pubmed-meshheading:18250412... | lld:pubmed |
pubmed-article:18250412 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18250412 | pubmed:articleTitle | pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules. | lld:pubmed |
pubmed-article:18250412 | pubmed:affiliation | Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, 1000 Veteran Avenue, Los Angeles, CA 90095, USA. rpsingh@mednet.ucla.edu | lld:pubmed |
pubmed-article:18250412 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18250412 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18250412 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18250412 | lld:pubmed |